🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Recapping the last 24 hours of Pfizer-Starboard drama: Earlier today, Endpoints News broke the news of how a blank, seemingly accidental email tipped off this week's drama: endpts.com/behind-the-sce…

The pharma industry’s DC-based lobbying group urged the federal government on Friday to get on board with alternative models for 340B drug price discounts. endpts.com/exclusive-phrm…

The Endpoints News Weekly has a new look! If you haven't already, sign up here to get our weekly recap of can't-miss biopharma news in your inbox on Saturday mornings: endpts.com/subscribe/ endpts.com/dna-edit-leads…

Exclusive: Biogen will cut jobs in its research unit to refocus on external opportunities and a streamlined preclinical portfolio, aiming for faster proof-of-concept in trials. endpts.com/exclusive-biog…

AstraZeneca says it plans to participate in another round of Medicare negotiations under the IRA. But a company executive told me it's dealing with a whole new set of considerations this time around: endpts.com/astrazeneca-ex…

Novo Nordisk is asking a federal appeals court to hurry up on its case challenging the Inflation Reduction Act’s drug pricing provisions. endpts.com/novo-nordisk-a…

AstraZeneca and Daiichi Sankyo redefined how breast cancer patients are classified when Enhertu was approved for HER2-low patients. Now they're expanding to "ultralow" patients. endpts.com/astrazeneca-da…

The Trump administration said it will consider “opportunities to bring greater transparency” to the Medicare drug price negotiation process under the Inflation Reduction Act. CMS said it intends to get input from stakeholders. endpts.com/trump-administ…

My Endpoints colleagues shared minute-by-minute updates on the Senate confirmation hearing for Robert F. Kennedy Jr. today. Check it out here: endpts.com/kennedy-hearin…

Takeda CEO Christophe Weber will step down next June. Julie Kim, the current president of Takeda’s US business unit, will succeed Weber and will be the company’s first female CEO. endpts.com/takeda-ceo-chr…

An NIH cap on indirect cost payments for grant recipients is casting a shroud of uncertainty for research universities despite a judge’s order to block it. endpts.com/nihs-funding-c…

This just in: A federal judge in Massachusetts extended a temporary nationwide block on the NIH’s 15% cap on indirect cost reimbursements for grant recipients. Read more in our blog: endpts.com/trump-healthca…

Eli Lilly will start selling additional single-dose vials of its weight loss drug Zepbound at a lower price for certain patients. endpts.com/eli-lilly-expa…

Trump's NIH pick Jay Bhattacharya appears headed for a relatively easy Senate confirmation, following a two-hour hearing on Wednesday. The Endpoints News crew has minute-by-minute updates here: endpts.com/bhattacharya-h…

A federal judge on Wednesday blocked the NIH from issuing a cap on indirect cost payments for grantees after finding that the challengers are likely to show the cuts conflict with the law. endpts.com/judge-grants-n…

“I do believe that any child who dies of a vaccine-preventable illness is a tragedy in the modern era,” FDA nominee Marty Makary said during a Senate hearing today. Read more here: endpts.com/makary-hearing…

The Trump administration defended HHS’ rejection of drugmakers’ 340B rebate models “at this time." But when it comes to the companies’ proposed models, the agency specified that it “never said never.” endpts.com/trumps-hhs-def…

The second round of Medicare price negotiations is now underway for all 15 selected drugs with signed agreements in place from the manufacturers of those drugs. endpts.com/all-selected-d…